First batch of DRDO’s anti-COVID drug 2-DG launched
The first batch of 10,000 doses of 2DG medicine would be launched early next week, informed DRDO officials to ANI on Friday.
By ANI| Posted by Sakina Fatima | Updated: 17th May 2021 1:17 pm IST Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the DRDO.
New Delhi: Defence Minister Rajnath Singh and Union Health Minister Dr Harsh Vardhan on Monday released the first batch of Anti-COVID drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO).
DRDO says its anti-COVID drug 2-DG should work against various strains - The first batch of the anti-COVID drug was released by Defence Minister Rajnath Singh and Union Health Minister Harsh Vardhan on Monday.
The launch of the DRDO s new anti-COVID drug.
DRDO s anti-COVID drug reduces average recovery time by 2.5 days, oxygen demand by 40pc: Govt ANI | Updated: May 17, 2021 22:25 IST
New Delhi [India], May 17 (ANI): The DRDO s new anti-COVID drug, 2-DG, reduces a patient s average recovery time by two and a half days and oxygen demand by upto 40 per cent, the Union Health Ministry informed on Monday.
In a statement, the ministry informed that anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by the Defence Research and Development Organisation s Institute of Nuclear Medicine and Allied Sciences (INMAS), along with Dr Reddy s Laboratories.
Deepak Sapra, CEO, Pharmaceutical Services and Active Pharmaceutical Ingredients, Dr. Reddy s labs. (Photo/ANI)
DRDO s anti-COVID 2-DG drug an add-on, not substitute for other medicines: Dr Reddy s CEO ANI | Updated: May 17, 2021 19:15 IST
Hyderabad (Telangana) [India], May 17 (ANI): The DRDO s new anti-COVID drug 2DG is an add-on and not a substitute for any of the drugs that are used to treat coronavirus patients, said Deepak Sapra, the CEO of Pharmaceutical Services and API, Dr. Reddy s labs.
Speaking to ANI, Sapra said that 2DG is a molecule developed by Dr. Reddy s labs in partnership with DRDO s INMAS (Institute of Nuclear Medicine & Allied Sciences), and was originally developed for the treatment of cancer.
Govt Shifts DRDO Hospital Out Of Budgam
The basic spade work going for 500-bed DRDO special hospital for Covid-19 in a Budgam village.
The hospital will now come up at Khunmoh where the administration has located a building. Officials said the soil test report was not supportive of the construction because of the marshy land and that shifted to a pre-constructed facility was simply aimed at saving time.
The hospital envisages 125 fully equipped ICU beds for Covid19 patients and a 50-double room accommodation facility for doctors and paramedic staff.
The shifting is being seen as depriving Budgam of a major facility. But the Deputy Commissioner Budgam, Shahbaz Mirza has said the hospital was not a permanent facility. He has said the government plans to set up a district hospital on the piece of land.